Details

Notice to stakeholders: Release of guidance document: Information and submission requirements for biosimilar biologic drugs for the addition of an indication where there is no/minimal data required to accompany the submission - Canada.ca

Metadata and links for an archived snapshot.

Source: Health Canada
Date: Mar 6, 2026 · edition #6
Timestamp: 2026-03-06T02:30:27.542Z
Language: en
Original URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/notice-stakeholders-guidance-biosimilar-biologic-drugs-submission-requirements-no-minimal-data.html
Replay URL: https://replay.healtharchive.ca/job-6/20260306023027/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/notice-stakeholders-guidance-biosimilar-biologic-drugs-submission-requirements-no-minimal-data.html#ha_snapshot=605600
ID: 605600
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots